Abstract
The introduction of a hydroxyl group “biohydroxylation” in the steroid skeleton is an important step in the synthesis of new steroids used physiologically as hormones and active drugs. There are currently about 300 known steroid drugs whose production constitutes the second category within the pharmaceutical market after antibiotics. Several biotransformations at industrial scale have been applied in the production of steroid hormones and drugs, which have functionalized different types of raw materials by means of chemo-, regio-, and stereoselective reactions (hydroxylation, Baeyer-Villiger oxidation, oxidation reactions, reduction of group carbonyl, isomerization, and Michael additions, condensation reactions, among others). In Green Chemistry, biotransformations are an important chemical methodology toward more sustainable industrial processes.
Keywords
- biotransformation
- steroid compounds
- biological transformation
- bioconversions
- microorganisms
1. Introduction
Steroids (stereos = solids) are organic compounds derived from alcohols, which are widely distributed in the animal and plant kingdoms. Their base skeleton has 17 carbon atoms in a tetracyclic ring system known as cyclopentanoperhydrophenanthrenes (gonane and estrane). In this group of substances, life-vital compounds are categorized, such as cholesterol, bile acids, sex hormones, vitamin D, corticosteroids, cardiac aglycones, and antibiotics, among others.
Some of the most potent toxins are steroid alkaloids. Steroids are responsible for important biological functions in the cell; for example, the steroids derived from androstane, pregnane, and estrane have hormonal activity [1, 2, 3, 4, 5]; bile acids are important for the digestion and absorption of fats; and cardiotonic aglycones are used for the treatment of heart disease. Sterols are constituents of the cell membrane, essential for cell stability and development; also, they are precursors of bile acids and steroid hormones.
A large number of steroids are used as anti-inflammatory agents [6], immunosuppressants, progestational agents, diuretics, anabolics, and contraceptives [7, 8, 9]. Some are used for the treatment of prostate and breast cancer [10, 11], for adrenal insufficiency [12], for prevention of heart disease [13], as antifungal agents [14], and as active ingredients used for the treatment of obesity [15] and AIDS [16]. Recently, the antiviral activity against the herpes simplex virus type I of some steroid glycosides was determined [17].
The therapeutic action of some steroid hormones has been associated with their interaction with intracellular receptors, which act as transcription factors in the regulation of gene expression [18]. It has been reported that some steroids, such as dehydroepiandrosterone (DHEA), progesterone, pregnenolone and its sulfated derivatives [19, 20], as well as, 17β-estradiol, allopregnanolone and its synthetic derivatives (afoxolaner and ganaxolone) are considered neurosteroids, due to their action at the level of the CNS [19].
The physiological activity of steroids depends on their structure, the type, number, spatial orientation, and reactivity of the different functional groups present in the tetracyclic core as well as the oxidation state of the rings. For example, the presence of an oxygenated function in C-11β is crucial for the anti-inflammatory activity; the hydroxyl function in C-17β determines androgenic properties; the aromatization of ring A confers estrogenic effect; and corticosteroids have the 3-keto-4-ene group and the pregnane side chain at C-17 [21, 22].
Currently, about 300 steroid drugs are known, and this number tends to grow. Their production represents the second category in the pharmaceutical market after antibiotics [24, 25]. Nowadays, steroids represent one of the largest sectors in pharmaceutical industry with world markets in the region of US$ 10 billion and the production exceeding 1,000,000 tons per year [23].
The production of steroid drugs and hormones is one of the best examples of the applications that biotransformations have on an industrial scale [3, 21]. Microbiological transformations are an effective tool for the preparation of various compounds [26], which can be difficult to obtain by conventional chemical methods and have been widely used in the bioconversion of steroids [25]. In 1950, the pharmacological effects of cortisol and progesterone were reported, in addition to the hydroxylation of the latter in C-11α using
Currently, a great versatility of microbial systems in the pharmaceutical industry for the commercial production of steroids and other drugs is recognized [27, 28]. Several hundreds of microbiological transformations of steroids have been reported in the literature; also, many bioconversions have been incorporated into numerous partial syntheses of new compounds for their evaluation such as hormones or drugs [21, 29, 30, 31, 32]. Chemical derivatives of some steroids are reported to have better therapeutic advantages than the starting materials.
However, the main objectives in the research and development of the steroid drug industry currently consist of the detection and isolation of microbial strains with novel activity or more efficient transformation capacity, where genetic engineering and metabolic engineering can play a prominent role in the metabolism of bacteria, fungi, and plants [33, 34, 35, 36].
The aim of the present review is to emphasize the importance of biotransformation using microorganisms to obtain steroid compounds with pharmaceutical interest, as a chemical-biological strategy that alternates with the chemical synthesis, and to highlight the chemical reaction made by different types of microorganisms in the functionalization of the steroid skeleton.
2. Microbiological transformations of steroids
In Green Chemistry, biotransformations constitute an important methodology in organic chemistry [37]. The microbiological transformations of steroids have been an essential chemical tool used for the preparation of many intermediaries and in the generation of new drugs, where chemical functionalization-hydroxylation, Baeyer-Villiger oxidation, reduction, isomerization, Michael additions, and condensation reactions can be carried out in different positions of the steroid skeleton in
In the literature, it is the well-documented
From the incubation of
In the incubation of
An efficient
Recently, it was reported that in the biotransformation of
In the biotransformation of 5β-dihydroprogesterone (
The biotransformation of 16-dehydroprogesterone (4,16-pregnadien-3,20-dione,
In contrast, in the biotransformation of 17α-hydroxyprogesterone (
Pregnenolone (3β-hydroxypregn-5-en-20-one,
The microbiological transformation of the racemic mixture of 13-ethyl-17β-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one (
The racemic mixture (±)-13-ethyl-7β,17β-dihydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one (
The biotransformation of danazol (17β-hydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole,
Norethisterone (17α-ethynyl-19-nortesterone,
Mestranol (
Microbial transformation of 6-dehydroprogesterone (
Incubation of melengestrol acetate (
Biotransformation of 3β-hydroxy-17β-carboxyethyl-5β-androstenol (
Androst-4-en-3,17-dione (
In the bioconversion of
Obtaining hydroxylated derivatives in a specific position is one of the objectives of the steroid industry; for example, 14α-hydroxysteroids are shown to have anti-inflammatory, contraceptive, and antitumor activities. With the biotransformation of
Androsta-1,4-dien-3,17-dione (
Testosterone (
In the biotransformation of
In the biotransformation of
Incubation of
Dehydroepiandrosterone (3β-hydroxyandrost-5-en-17-one,
In the biotransformation of
The biotransformation of 17α-ethynyl-17β-hydroxyandrost-4-en-3-one (ethisterone,
Adrenosterone (
The biotransformation of mesterolone (1α-methyl-17β-hydroxy-5α-androst-3-one,
In the microbiological transformation of 3-hydroxyestra-1,3,5-(10)-trien-17-one (
Prednisone (
The main chemical transformation carried out by different
Incubation of 17β-methoxy-5α-androst-3-one (
In the literature, several species of fungi belonging to the genera
The ethynodiol diacetate (
Desogestrel (13-ethyl-17-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol,
The drugs mexrenone (
One of the steroids used in the treatment of breast cancer is exemestane (
4-Hydroxyandrost-4-ene-3,17-dione (formestane,
Methyltestosterone (
Dianabol (methandrostenolone, 17α-methyl-17β-hydroxyl-androst-1,4-dien-3-on,
Methasterone (
3. Conclusions
The biotransformation processes of different steroid compounds described in this review, although not exhaustive, aim to highlight the importance of biotransformation through different microorganisms, as a useful chemical-biological tool for obtaining novel derivatives for research purpose and as industrial applications. An example includes obtaining steroid compounds for the pharmaceutical industry.
Biotransformation of steroids has been implemented in an important way in the partial synthesis of new steroids, for their evaluation as hormones and drugs. Currently, there is a wide variety of steroids used as diuretics, anabolic, anti-inflammatory, antiandrogenic, anticontraceptive, antitumor, among other applications. Chemical functionalization in different carbon atoms of the sternum skeleton is related to the biological activity of the molecule. This is why microbiological transformations play an important role in obtaining these compounds through chemical transformations, such as the oxidation of hydroxyl group at C-3 and C-17, isomerization of the double bond Δ5(6) to Δ4(5), hydrogenation of double bonds Δ1(2) and Δ4(5), and reduction of the carbonyl group at C-17 and C-20 with β orientation. Biohydroxylations performed in different positions of the steroid skeleton—C-11α, C-11β, C-15β, and C-16α—using different species of fungi of the genera
Hydroxylation of steroids—progesterone, testosterone, 17α-methyltestosterone, and 4-androsten-3,17-dione—presenting the 4-en-3-one system, proceeds with a high stereo- and regioselectivity in the C-6 and C-11 positions, with a β orientation in C-6 and α orientation in C-11. The presence of the methyl group in C-10 is necessary for the hydroxylation in C-11, as can be seen in the derivatives of 19-nortesterone.
The interest in the biotransformation of steroid compounds has been increasing in recent years, due to the obtaining of new and useful pharmacologically active compounds. In addition to the development of new genetically modified strains, there is an increase in the availability of immobilized enzymes and the manipulation of culture media.
Biotransformation of steroids proceeds with low to moderate yields in general. One of the main causes is their low solubility in water. Currently, methodologies are developed that allow the incorporation of chemicals—surfactants, ionic liquids, cyclodextrins, liposomes, among others—that contribute to improve the yields of each biotransformation process and the processes friendly to the environment.
Acknowledgments
A la Carrera de Biología, FES-Zaragoza, UNAM. Ms. Fabiola Cano thank for her suggestions and comments toward improving the manuscript.
References
- 1.
Mensah-Nyagan AG, Meyer L, Schaeffer V, Kibaly C, Patte-Mensah C. Evidence for a key role of steroids in the modulation of pain. Psychoneuroendocrinology. 2009; 34 :169-177. DOI: 10.1016/j.psyneuen.2009.06.004 - 2.
Funder JW. Minireview: Aldosterone and mineralocorticoid receptors: Past, present, and future. Endocrinology. 2010; 151 :5098-5102. DOI: 10.1210/en.2010-0465 - 3.
Fernandez P, Cruz A, Angelova B, Pinheiro HM, Cabral JMS. Microbial conversion of steroid compounds: Recent developments. Enzyme and Microbial Technology. 2003; 32 :688-705. DOI: 10.1016/S0141-0229(03)00029-2 - 4.
Hogg JA. Steroids, steroids community and Upjohn in perspective: A profile of innovation. Steroids. 1992; 257 :593-616 - 5.
Sedlaczek L. Biotransformations of steroids. Critical Reviews in Biotechnology. 1988; 7 :187-236. DOI: 10.3109/07388558809146602 - 6.
Ko D-H, Heiman AS, Chen M, Lee HJ. New steroidal anti-inflammatory antedrugs: Methyl 21-desoxy-21-chloro-11β,17α-dihydroxy-3,20-dioxo-1,4-pregnadiene-16α-carboxylate, methyl 21-desoxy-21-chloro-11β-hydroxy-3,20-dioxo-1,4-pregnadiene-16α-carboxylate, and their 9α-fluoro derivatives. Steroids. 2000; 65 :210-218 - 7.
Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulus C. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities: Applied modifications in the steroidal structure. Steroids. 2009; 74 :172-197. DOI: 10.1016/j.steroids.2008.10.016 - 8.
Agoston ES, Hastcher MA, Kensler TW, Posner GH. Vitamin D analogs as anti-carcinogenic agents. Anti-Cancer Agents in Medicinal Chemistry. 2006; 6 :53-71. DOI: 10.2174/187152006784111369 - 9.
Tuba Z, Barden CW, Dancsi A, Francsics-Czinege E, Molnar EC, Csorgei J, et al. Synthesis and biological activity of a new progestogen, 16-methylene-17α-hydroxy-18-methyl-19-norpregn-4-ene-3,20-dione acetate. Steroids. 2000; 65 :266-274. DOI: 10.1016/S0039-128X(99)00109-9 - 10.
Siemes C, Visser LE, De-Jong FH, Jan-Willem Coebergh W, Uitterlinden AG. Cytochrome P450 3A gene variation, steroid hormone serum levels and prostate cancer. Steroids. 2010; 75 :1024-1032. DOI: 10.1016/j.steroids.2010.07.001 - 11.
Diaz-Chico BN, Rodriguez FG, Gonzalez A, Ramirez R, Bilbao C, Leon AC, et al. Androgens and androgen receptores in breast cáncer. Journal of Steroid Biochemistry and Molecular Biology. 2007; 105 :1-15. DOI: 10.1016/j.jsbmb.2006.11.019 - 12.
Johnston JO. Aromatase inhibitors. In: Parish EJ, Nes WD, editors. Biochemistry and Function of Sterols. Boca Raton, FL: CRC Press; 1987. pp. 23-53 - 13.
Craigie E, Mullins JJ, Bailey MA. Glucocorticoids and mineralocorticoids. In: Bader M, editor. Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics. Weinheim: Wiley-VCH Verlag GmbH & Co; 2009. pp. 1-64 - 14.
Chung SK, Ryoo CH, Yang HW, Shim JY, Kang MG, Lee KW, et al. Synthesis and bioactivites of steroids derivatives as antifungal agents. Tetrahedron. 1998; 52 :15899-15914. DOI: 10.1016/S0040-4020(98)01000-X - 15.
Suzuki K, Nakata T, Shimizu T, Enomoto K. Anti-obesity agents. US Patent 5,846,962; 1998 - 16.
Dombrowski AW, Hazuda DJ, Polishook JD, Felock PJ, Singh SB, Zink DL. HIV-integrase-inhibitors. WO Patent 0036132; 2000 - 17.
Athan D, Svasti J, Kittakoop P, Pittayakhachonwut D, Tanticharpen M, Thebtaranoth Y. Antiviral isoflavonoid sulfate and steroidal glycoside from the fruits of Solanum torvum . Phytochemistry. 2002;59 :459-463. DOI: 10.1016/S0031-9422(01)00417-4 - 18.
Rupprecht R, Holsboer F. Neuoroactive steroids: Mechanisms of action and neuropsychopharmacology perspectivs. Trends in Neurosciences. 1999; 22 :410-416. DOI: 10.1016/S0166-2236(99)01399-5 - 19.
Mellon SH, Griffin LD. Neurosteroids: Biochemistry and clinical significance. Trends in Endocrinology and Metabolism. 2002; 13 :35-43. DOI: 10.1016/S1043-2760(01)00503-3 - 20.
Baulieu E-E, Schumacher M. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids. 2000; 65 :605-612 - 21.
Fernandez P, Cabral JMS. Steroid bioconversion. In: Flickinger M, editor. Enciclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology. New York: John Wiley & Sons, Inc.; 2010. pp. 1-32 - 22.
Donova MV, Ergova OV. Microbial steroid transformations: Current state and prospect. Applied Microbiology and Biotechnology. 2012; 94 :1423-1447. DOI: 10.1007/978-1-4939-7183-1 - 23.
Sultana N. Microbial biotransformation of bioactive and clinically useful steroids and some salient features of steroids and biotransformation. Steroids. 2018; 136 :76-92. DOI: 10.1016/j.steroids.2018.01.007 - 24.
Tong W-Y, Dong X. Microbial biotransformation: Recent developments on steroid drugs. Recent Patents on Biotechnology. 2009; 3 :141-153 - 25.
Bureik M, Bernhardt R. Steroid hydroxilation: Microbial steroid biotransformation using cytochrome P450 enzymes. In: Schmid RD, Urlacher VB, editors. Modern Bioxidation: Enzymes, Reactions and Applications. Wienheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2007. pp. 155-176 - 26.
Lehman LR, Stewart JD. Filamentous fungi: Potentially useful for the biohydroxilation of non-actived carbón centres. Current Organic Chemistry. 2001; 5 :439-470. DOI: 10.2174/1385272013375490 - 27.
Pollard DJ, Woodley JM. Biocatalysis for pharmaceutical intermediates: The future is now. Trends in Biotechnology. 2006; 25 :66-72. DOI: 10.1016/j.tibtech.2006.12.005 - 28.
Straathof AJJ. The production of fine chemicals by biotransformation. Current Opinion in Biotechnology. 2002; 13 :548-546. DOI: 10.1016/S0958-1669(02)00360-9 - 29.
Mahato SB, Majumdar I. Current trends in microbial steroid biotransformation. Phytochemistry. 1993; 34 :883-898. DOI: 10.1016/S0031-9422(00)90685-X - 30.
Mahato SB, Garai S. Advances in microbial steroid biotransformation. Steroids. 1997; 62 :332-345. DOI: 10.1016/S0039-128X(96)00251-6 - 31.
Donova MV. Transformation of steroids by actinobacteria. Applied Biochemistry and Microbiology. 2007; 43 :1-14 - 32.
Prabha V, Ohri M. Review: Bacterial transformations of bile acids. World Journal of Microbiology and Biotechnology. 2006; 22 :191-196. DOI: 10.1007/s11274-005-9019-y - 33.
Huttel W, Hoffmeister D. Fungal Biotransformation in pharmaceutical sciences. In: Hofrichter M, editor. Industrial Applications, the Mycota. Berlin: Springer; 2010. pp. 293-317 - 34.
Petric S, Hakki T, Bernhardt R, Zigon D, Cresnar B. Discovery of a steroid 11α-hydroxylase from Rhizopus oryzae and its biotechnological application. Journal of Biotechnology. 2010;150 :428-437. DOI: 10.1016/j.jbiotec.2010.09.928 - 35.
Rodina NV, Andryushina VA, Stysenko TS, Turova TP, Baslerov RV, Panteleeva AN, et al. The introduction of the 9α-hydroxy group into andros-4-en-3,17-dione using a new actinobacterium strain. Applied Biochemistry and Microbiology. 2009; 45 :395-400 - 36.
Faber K, Kroutil W. New enzymes for biotransformation. Current Opinion in Chemical Biology. 2005; 9 :181-187. DOI: DOI 10.1016/j.cbpa.2005.01.0 - 37.
Ran N, Zhao L, Chen Z, Tao J. Recent applications of biocatalysis in developing green chemistry for chemical synthesis at the industrial scale. Green Chemistry. 2008; 10 :361-372. DOI: 10.1039/b716045c - 38.
Hu SH, Genain G, Azerad R. Microbial transformation of steroids: Contribution to 14α-hidroxilations. Steroids. 1995; 60 :337-352 - 39.
Smith KE, Ahmed F, Williams RAD, Kelly SL. Microbial transformations of steroids-VIII. Transformation of progesterone by whole cells and microsomes of Aspergillus fumigatus . The Journal of Steroid Biochemistry and Molecular Biology. 1994;49 :93-100 - 40.
Khalil AM, Eman MM. Microbiological transformation of progesterone by some zoosporic fungi. Journal of Basic Microbiology. 1996; 36 :255-259 - 41.
Javid M, Nickavar B, Vahidi H, Faramarzi MA. Baeyer-Villiger oxidation of progesterone by Aspergillus sojae PTCC 5196. Steroids. 2018;140 :52-57. DOI: 10.1016/j.steroids.2018.07.008] - 42.
Kolek T, Swizder A. Biotransformation XLV. Transformations of 4-ene-3-oxosteroids in Fusarium culmorum culture. The Journal of Steroid Biochemistry and Molecular Biology. 1998;67 :63-69 - 43.
Al-Awadi S, Afzal M, Oommen S. Studies on Bacillus stearithermophillus . Part I. Transformation of progesterone to a new metabolite 9,10-seco-4-pregnene-3,9,20-trione. The Journal of Steroid Biochemistry and Molecular Biology. 2001;78 :493-498 - 44.
Kolet SP, Niloferjahan S, Haldar S, Gonnade R, Thulasiram HV. Biocatalyst mediated production of 6β,11α-dihydroxy derivatives of 4-ene-3-one steroids. Steroids. 2013; 78 :1152-1158. DOI: 10.116/j.steroids.2013.08.00 - 45.
Eshrat G-F, Aroona C. Biotransformation of progesterone by Penicillum aurantiogriseum . Research Journal of Microbiology. 2011;6 :98-104. DOI: 10.3923/jm.2011.98.104 - 46.
Gopal SKV, Naik S, Somal P, Sharma P, Arjuna A, Hassam R, et al. Production of 17-ketoandrostene steroids by the side chain cleavage of progesterone with B. sphaericus . Biocatalysis and Biotransformation. 2008;26 :272-279. DOI: 10.1080/10242420701707637 - 47.
Al-Beloshei NE, Al-Awadhi HA, Al-Khalaf RAR, Oommen S, Afzal M. Biocatalyzed transformation of progesterone by Geobacillus gargensis DSM 15378. Applied Biochemistry and Microbiology. 2015;51 :321-328 - 48.
Gas KP, Sakac M, Jovanovic-Santa S, Djurendic E. An overview of partial synthesis and transformations of secosteroids. Current Organic Chemistry. 2014:216-259. DOI: 10.2174/138527281131176660147.] - 49.
Lin Z, Marepally SR, Ma D, Kim T-K, Oak ASW, Myers LK, et al. Synthesis and biological evaluation of vitamin D3 metabolite 20S,23S-dihydroxyvitamin D3 and its 23R epimer. Journal of Medicinal Chemistry. 2016:136, 5102-5108. DOI: 10.1021/acs.jmedchem.6b00182 - 50.
Madyastha KM, Joseph T. Transformation of 16-dehydroprogesterone and 17α-hydroxyprogesterone by Mucor piriformis . Applied Microbiology and Biotechnology. 1994;41 :170-177 - 51.
Madyastha KM, Joseph T. Transformation of dehydroepiandrosterone and pregnenolone by Mucor piriformis . Applied Microbiology and Biotechnology. 1995;44 :339-343 - 52.
Shan L-H, Liu H-M, Huang K-H, Dai G-F, Cao C, Dong R-J. Synthesis of 3β,7α,11α-trihidroxy-pregn-21-benzylidene-5-en-20-one derivatives and their cytotoxic activities. Bioorganic & Medicinal Chemistry Letters. 2009; 19 :6637-6639. DOI: 10.1016/j.bmcl.2009.10.019 - 53.
Farooq A, Tahara S. Biotransformation of testosterone and pregnenolone catalyzed by the fungus Botrytis cinerea . Journal of Natural Products. 2000;63 :489-491. DOI: 10.1021/np990520b - 54.
Choudhary MI, Batool I, SAA S, Nawaz SA, Ali Shah SA, Atta-ur-Rahman. Microbial hydroxylation of pregnenolone derivatives. Chemical & Pharmaceutical Bulletin. 2005; 55 :1455-1459 - 55.
Schaaaf O, Dettner K. Transformation of steroids by Bacillus strains isolated from the foregut of water beetles (Coloptera: Dytiscidae): II. Metabolism of 3β-hydroxypregn-5-en-20-one (pregnenolone). The Journal of Steroid Biochemistry and Molecular Biology. 2000;75 :187-199 - 56.
Wilson MR, Gallimore WA, Reese PB. Steroid transformations with Fusarium oxysporum var. cubense andColletotrichum musae . Steroids. 1999;64 :834-843. DOI: 10.1016/S0039-128X(99)00067-7 - 57.
Hu SH, Tian XF, Sun YH, Han GD. Microbial hydroxylation of 13-ethyl-17β-hydroxy-18,19-dinor-17α-pregn-4-en-20-in-17-ona. Steroids. 1996; 61 :407-410 - 58.
Hu SH, Tian XF, Han GD. Novel microbial hydroxylation of 13-ethyl-17β-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one. Steroids. 1998; 63 :88-92 - 59.
Choudhary MI, Azizuddin, Atta-ur-Rehman. Microbial transformation of danazol. Natural Product Letters. 2002; 16 :101-106. DOI: 10.1080/10575630290019994 - 60.
Baydoun E, Atia-tul-Wahab, Mehmood H, Ahmad MS, Malik R, Smith C, et al. Microbial transformation of danazol with Cunninghamella blakesleeana and anti-cancer activity of danazol and its transformed products. Steroids. 2016;105 :121-127. DOI: 10.1016/j.steroids.2015.11.010 - 61.
Choudhary MI, Musharraf SG, Ali RA, Atif M, Atta-ur-Rahman. Microbial transformation of antifertility agents. Norethisterone and 17α-ethynylestradiol. Zeitschrift für Naturforschung. 2004; 59B :319-323 - 62.
Choudhary MI, Musharraf SG, Ali-Siddiqui Z, Khan NT, Alli RA, Atta-ur-Rahman. Microbial transformation of mestranol by Cunninghamella elegans . Chemical & Pharmaceutical Bulletin. 2005;53 :1011-1013 - 63.
Ahmad MS, Zafar S, Yousuf S, Atta-tul-Wahab, Atta-ur-Rahman, Choudhary MI. Biotransformation of 6-dehydroprogesterone with Aspergillius niger andGibberella fujikuroi . Steroids. 2016;112 :62-67. DOI: 10.1016/j.steroids.2016.04.008 - 64.
Peterson DH, Nathan AH, Meister PD, Eppstein SH, Murray HC, Weintraub A, et al. Microbiological transformation of steroids VI. Preparation of 11α-hydroxy-6-dehydroprogesterone. Journal of the American Chemical Society. 1953; 75 :419-421 - 65.
Smith KE, Latif S, Kirk DN, White KA. Microbial transformations of steroids IV. 6,7-dehydrogenation; a new class of fungal steroids transformation product. Journal of Steroid Biochemistry. 1989; 33 :271-276. DOI: 10.1016/0022-4731(89)90304-X - 66.
Baydoun E, Bano S, Atia-tu-Wahab, Jabeen A, Yousuf S, Mesaik A, et al. Fungal transformation and T-cell proliferation inhibitory activity of melengestrol acetate and its metabolite. Steroids. 2014; 86 :56-61. DOI: 10.1016/j.steroids.2014.04.012 - 67.
Madyasth KM. Novel microbial transformation of steroids. Advances in Experimental Medicine and Biology. 1995; 405 :259-270 - 68.
Angelova B, Mutafov S, Avramova T, Dimova I, Boyadjieva L. 9α-Hydroxylation of 4-androstene-3,17-dione by resting Rhodococcus sp. cells. Process Biochemistry. 1996;31 :179-184 - 69.
Schaaaf O, Dettner K. Transformation of steroids by Bacillus strains isolated from the foregut of water beetles (Coleoptera: Dytiscidae): I. Metabolism of androst-4-en-3,17-diona (AD). The Journal of Steroid Biochemistry and Molecular Biology. 1998;67 :451-465 - 70.
Hanson JR, Nasir H, Pervez A. The hydroxilation of testosterone and some derivates by Cephaslosporium aphidicola . Phytochemistry. 1996;42 :411-415 - 71.
Choudhary MI, Sultan S, MTH K, Yasin A, Shaheen F, Atta-ur-Rehman. Biotransformation of (+)-androst-4-ene-3,17-diona. Natural Product Research. 2004; 18 :529-535. DOI: 10.1080/14786410310001620628 - 72.
Xiong Z, Wei Q , Chen H, Chen S, Xu W, Qiu G, et al. Microbial transformation of androst-4-en-3,17-dione by Beauveria bassiana . Steroids. 2006;71 :979-983. DOI: 10.1016/j.steroids.2006.07.007 - 73.
Janeczko T, Dmochowska-Gładysz J, Kostrzewa-Susłow E, Białonska A, Ciunikb Z. Biotransformations of steroid compounds by Chaetomium sp. KCH 6651. Steroids. 2009;74 :657-661. DOI: 10.1016/j.steroids.2009.02.006 - 74.
Andryushina VA, Voishvillo NE, Druzhinina AV, Stytsenko TS, Yaderets VV, Petrosyan MA, et al. 14α-hydroxylation of steroids by mycelium of the mold fungus Curvularia lunata (VKPM F-981) to produce precursors for synthesizing new steroidal drugs. Pharmaceutical and Chemical Journal. 2013;47 :103-108 - 75.
Qiao Y, Shen Y, Huang W, Wang Y, Ren J, Xia T, et al. Biocatalyst-mediated production of 11,15-dihydroxy derivates of androst-1,4-dien-3,17-dione. Journal of Bioscience and Bioengineering. 2017; 123 :692-697. DOI: 10.1016/j.jbiosc.2017.01.008.], 10.1016/j.jbiosc.2017.01.008.] - 76.
Ahmed F, Williams RAD, Smith KE. Microbial transformations of steroids-X. Cytochromes P-450 11α-hydroxylase and C17-C20 lyase and a 1-ene-dehydrogenase transform steroids in Nectria haematococca . The Journal of Steroid Biochemistry and Molecular Biology. 1996;58 :337-349. DOI: 10.1016/0960-0760(96)00032-5 - 77.
Atta-ur-Rahman, Choudhary MI, Asif F, Farooq A, Yaqoob M. Microbial transformations of testosterone. Natural Product Letters. 1998; 12 :255-261. DOI: 10.1080/10575639808048299 - 78.
Al-Awadi S, Afzal M, Oommen S. Studies of Bacillus stearothermophilus . Part III. Transformation of testosterone. Applied Microbiology and Biotechnology. 2003;62 :48-52. DOI: 10.1007/s00253-003-1269-8 - 79.
Al-Awadi S, Afzal M, Oommen S. Studies on Bacillus stearothermophilus . Part IV. Influence of enhancers on biotransformation of testosterone. Steroids. 2005;70 :323-327 - 80.
Wu Y, Li H, Zhang XM, Gong JS, Ra ZM, Shi JS, et al. Efficient hydroxylation of functionalized steroids by Colletotrichum lini ST-1. Journal of Molecular Catalysis B: Enzymatic. 2015;120 :111-118. DOI: 10.1016/j.molcatb.2015.07.003 - 81.
Choudhary MI, Ali Shah SA, Musharraf SG, Shaheen F, Atta-ur-Rahman. Microbial transformation of dehydroepiandrosterone. Natural Product Research. 2003; 17 :215-220. DOI: 10.1080/1057563021000040835 - 82.
Huang L-H, Li J, Xu G, Zhang X-H, Wang Y-G, Yin Y-L, et al. Biotransformación of dehydroepiandrosterone (DHEA) with Penicillum griseopurpureum Smith andPenicillum glabrum (Wehmer) Westling. Steroids. 2010;75 :1039-1046. DOI: 10.1016/j.steroids.2010.06.008 - 83.
Choudhary MI, Sultan S, Khan MTH, Atta-ur-Rehman. Microbial transformation of 17α-ethynyl- and 17α-ethylsteroids, and tyrosinase inhibitory activity of transformed products. Steroids. 2005; 70 :798-802. DOI: 10.1016/j.steroids.2005.05.002 - 84.
Musharraf SG, Atta-ur-Rahman, Choudhary MI, Sultan S. Microbial transformation of (+)-adrenosterone. Natural Product Letters. 2002; 16 :345-349. DOI: 10.1080/10575630290033105 - 85.
Choudhary MI, Sultan S, Jalil S, Anjum S, Rahman AA, Fun HK, et al. Microbial transformation of mesterelone. Chemistry & Biodiversity. 2005; 2 :392-400. DOI: 10.1002/cbdv.200590019 - 86.
Ahmad MS, Zafar S, Bibi M, Bano S, A-tul W, Atta-ur-Rahman, et al. Biotransformation of androgenic steroid mesterolone with Cunnighamella blakesleeana andMacrophomina phaseolina . Steroids. 2014;82 :53-59. DOI: 10.1016/j.steroids.2014.01.001 - 87.
Ahmada MS, Farooqa R, Hussaina N, Atia-tul-Wahabb, Atta-ur-Rahmana, Choudhary MI. Three new analogues of androgenic drug mesterolone through biotransformation with Cunninghamella blakesleeana . Journal of Molecular Catalysis B: Enzymatic. 2016;133 :S395-S399. DOI: 10.1016/j.molcatb.2017.03.001 - 88.
Choudhary MI, Siddiqui ZA, Musharraf SG, Nawaz SA, Atta-ur-Rahman. Microbial transformation of prednisone. Natural Product Research. 2005; 19 :311-317. DOI: 10.1080/14786410410001729168 - 89.
Faramarzi MA, Yazdi MT, Shafiee A, Zarrini G. Microbial transformation of hydrocortisone by Acremonium strictum PTCC 5282. Steroids. 2002;67 :869-872. DOI: 10.1016/S0039-128X(02)00049-1 - 90.
Choudhary MI, Sultan S, Yaqoob M, Musharraf SG, Yasin A, Shaheen F, et al. Microbial transformation of cortisol and prolyl endopeptidase inhibitory activities of its transformed products. Natural Product Research. 2003; 17 :389-395. DOI: 10.1080/14786410310001617640 - 91.
Kiran I, Hanson JR, Hunter AC. The microbiological hydroxylation of some methoxysteroids by Cephalosporium aphidicola . Journal of Chemical Research. 2004;5 :362-363. DOI: 10.3184/0308234041639827 - 92.
Jekkel A, Ilkoy E, Horvath G, Pallagi I, Süto J, Ambrus G. Microbial hydroxylation of 13β-ethyl-4-gonene-3, 17-dione. Journal of Molecular Catalysis B: Enzymatic. 1998; 5 :385-387. DOI: 10.1016/S1381-1177(98)00097-6 - 93.
Zafar S, Yousuf S, Kayani HA, Saifullah S, Khan S, Al-Majid AM, et al. Biotransformation of oral contraceptive ethynodiol diacetate with microbial and plant cell cultures. Chemistry Central Journal. 2012; 6 :109-116. DOI: 10.1186/1752-153X-6-109 - 94.
Atia-tul-Wahab, Siddiqui M, Ibrahin I, Hussain A, Ajandouz EH, Hijazi A, et al. Cunnighamella blakesleeana mediated biotransformation of a contraceptive drug, desogestrel, and anti-MDR-Staphylococcus aureus activity of its metabolites. Bioorganic & Medicinal Chemistry. 2018;77 :152-158. DOI: 10.1016/j.bioorg.2017.12.027 - 95.
Huyet J, Pinon GM, Fay MR, Fagart J, Rafestin-Oblin M-E. Structural basis of spirolactone recognition by the mineralocorticoid receptor. Molecular Pharmacology. 2007; 72 :563-571. DOI: 10.1124/mol.107.036459 - 96.
Preisig CL, Laakson JA, Mocek UM, Wang PT, Baez J, Byng G. Biotransformation of the cardiovascular drugs mexrenone and canrenone. Journal of Natural Products. 2003; 66 :350-356. DOI: 10.1021/np020347a - 97.
Baydoun E, Bibi M, Iqbal MA, Wanab A, Farran D, Smith C, et al. Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines. Chemistry Central Journal. 2013; 7 :57-63. DOI: 10.1186/1752-153X-7-57 - 98.
Martin GDA, Narvaez J, Bulmer R, Durrant MC. Biotransformation and molecular docking studies of aromatase inhibitor. Steroids. 2016; 113 :95-102. DOI: 10.1016/j.steroids.2016.07.003 - 99.
Martin GDA, Narvaez J, Marti A. Synthesis and bioconversions of formestane. Journal of Natural Products. 2013; 76 :1966-1969. DOI: 10.1021/np400585t - 100.
Torshabi M, Badiee M, Faramarzi MA, Rastegar H, Forootanfar H, Mohit E. Biotransformation of methyltestosterone by the filamentous fungus Mucor racemosus . Chemistry of Natural Compounds. 2011;47 :59-63 - 101.
Khan NT, Zafar S, Noreen S, Al Majid AM, Al Othman ZA, Al-Rasayes SI, et al. Biotransformation of dianabol with the filamentous fungi and β-glucoronidase inhibitory activity of resulting metabolites. Steroids. 2014; 85 :65-72. DOI: 10.1016/j.steroids.2014.04.004 - 102.
Bartmanska A, Dmochowska-Gladysz J, Huszcza E. Steroids transformation in Penicillum notatum culture. Steroids. 2005;70 :193-198. DOI: 10.1016/j.steroids.2004.11.011 - 103.
Bartmanska A, Dmochowska-Gladysz J. Transformation of steroids by Trichoderma hamatum . Enzyme and Microbial Technology. 2007;40 :1651-1621 - 104.
Huszcza E, Dmochowska-Gladysz J, Bartmanska A. Transformation of steroids by Beauveria bassiana . Zeitschrift für Naturforschung. 2005;60c :103-108 - 105.
Huszcza E, Dmochowska-Gladysz J. Transformation of testosterone and related steroids in Absidia glauca culture. Journal of Basic Microbiology. 2003;43 :113-120 - 106.
Brezezowska E, Dmochowska-Gladysz J, Kolek T. Biotransformation XXXIX. Metabolism of testosterone, androstenediona, progesterone and testosterone derivates in Absidia coerula culture. The Journal of Steroid Biochemistry and Molecular Biology. 1996;57 :357-362 - 107.
Huszcza E, Dmochowska-Gladysz J. Transformation of testosterone and related steroids by Botrytis cinerea . Phytochemistry. 2003;62 :155-158 - 108.
Ahmad MS, Yousuf S, Atia-tul-Wahab, Jabeen A, Atta-ur-Rahman, Choudhary MI. Biotransformation of anabolic compound methasterone with Macrophomina phaseolina ,Cunnighamella blackesleeana , andFusarium lini , and TNF-α inhibitory effect of transformed products. Steroids. 2017;128 :75-84. DOI: 10.1016/j.steroids.2017.04.001